← Product Code [IYN](/submissions/RA/subpart-b%E2%80%94diagnostic-devices/IYN) · K041675 # PICUS, PARUS, FALCO AND AQUILA ULTRASOUND SYSTEMS (K041675) _Pie Medical · IYN · Jul 23, 2004 · Radiology · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/RA/subpart-b%E2%80%94diagnostic-devices/IYN/K041675 ## Device Facts - **Applicant:** Pie Medical - **Product Code:** [IYN](/submissions/RA/subpart-b%E2%80%94diagnostic-devices/IYN.md) - **Decision Date:** Jul 23, 2004 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 892.1550 - **Device Class:** Class 2 - **Review Panel:** Radiology - **Attributes:** Pediatric ## Intended Use Pie Medical's Picus, Parus, Falco & Aquila Ultrasound Imaging Systems are to be used by or under the direction of a physician to perform general noninvasive and invasive diagnostic high resolution ultrasound imaging studies, to include: fetal, cardiac, transrectal, transvaginal, abdominal, neonatal cephalic, pediatric, peripheral vascular, small organs, intraoperative abdominal, intraoperative vascular, musculoskeletal (conventional and superficial) and wounds. ## Device Story Wound imaging method utilizes high-resolution ultrasound to evaluate wound extent. Procedure involves covering wound with sterile coupling gel and commercially available ultrasound couplant sheet (e.g., Civco HydroScan); ultrasound probe covered with sterile sheath (e.g., Civco). Linear or convex array transducer scanned over wound to acquire images. Clinician uses online measurement package to determine linear parameters, circumference, or depth for volume calculation. Output allows medical specialists to evaluate treatment efficacy by monitoring changes in wound area. Used in clinical settings by physicians or under their direction. Avoids adhesive edges on couplant sheets to prevent damage to sensitive periwound skin. ## Clinical Evidence Bench testing only. No clinical data provided. Substantial equivalence is based on technological similarities to predicate devices and the established use of ultrasound for wound imaging as demonstrated by the predicate Hudson system. ## Technological Characteristics Ultrasound imaging systems (Picus, Parus, Falco, Aquila) using linear/convex array transducers. Imaging modes include 2D, M-mode, and 3D (Picus). Electrical safety per EN60601-1; ultrasound safety per Track 1/3. Connectivity and software details not specified beyond standard measurement packages. ## Regulatory Identification An ultrasonic pulsed doppler imaging system is a device that combines the features of continuous wave doppler-effect technology with pulsed-echo effect technology and is intended to determine stationary body tissue characteristics, such as depth or location of tissue interfaces or dynamic tissue characteristics such as velocity of blood or tissue motion. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories. ## Predicate Devices - Picus ([K023512](/device/K023512.md) / K00288) - Parus ([K003725](/device/K003725.md)) - 100LC/100S/485 ([K002357](/device/K002357.md)) - Hudson 2020/2040/2060 Ultrasound Scanners ([K022928](/device/K022928.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ K041675 510(k) Summary Picus. Parus. Falco & Aquila Ultrasound stems Pie Medical # 510(k) Summary The following safety and effectiveness summary has been prepared pursuant to requirement for 510(k) summaries specified in 21CFR¶807.92(a). ### 807.92(a)(1) ## Submitter Information | Carri Graham, Official Correspondent | | |--------------------------------------|-------------------------------| | 7992 Castleway Drive | | | Indianapolis, IN 46250 | | | Phone: | (317) 849-1916, extension 103 | | Facsimile: | (317) 577-9070 | Contact Person: Carri Graham Date: June 18, 2004 807.92(a)(2) | Trade Name: | Ultrasound Imaging Systems | | |---------------------------|---------------------------------------------------------------------------|----------------------| | Common Name: | Ultrasound Imaging System | | | Classification Name(s): | Ultrasonic pulsed echo imaging system
Diagnostic Ultrasonic Transducer | 892.1560
892.1570 | | Classification Number: | 90IYO/90ITX | | | 807.92(a)(3) | Predicate Device(s) | | | Pie Medical | Picus | K023512 / K00288 | | Pie Medical | Parus | K003725 | | Pie Medical | 100LC/100S/485 | K002357 | | Hudson Diagnostic Imaging | Hudson 2020/2040/2060
Ultrasound Scanners | K022928 | Additional Substantial Equivalence Information is provided in the following substantial Equivalence Comparison Table. {1}------------------------------------------------ 510(k) Summarv Picus, Parus. Falco & Aquila Ultrasound Imaging Systems Pie Medical ### 807.92(a)(4) ### Device Description Wound imaging is a method for evaluating the extent of wounds, using high resolution ultrasound for image acquisition and applying the online measurement package of the ultrasound system to measure either the wounds' linear parameters, or the circumference and depth for volume determination. This information is used for the medical specialist to evaluate the efficacy of a particular treatment in the reduction of the wound area. The proposed wound imaging method uses a commercially available ultrasound couplant sheet, such as the Civco's HydroScan Couplant Sheet (Class 1), to cover a wound filled with a sterile coupling gel, such as Curasol (K953450). A linear or convex array ultrasound transducer is scanned over the covered wound to image the extent of the wound. Note that it is important that the cover not be sealed with adhesive edges area, as there is a potential to cause damage to the sensitive skin area adjacent to the wound. We believe that this is a significant advantage over previously described methods which use an adhesive material on the edge of the couplant sheet, and risk damaging the sensitive skin area proximal to the wound. To prevent contamination of the wound during the scan the ultrasound probe is covered with a commercially available sterile sheath, such as those available from Civco (K970515). The clinician can choose to perform area length or circumference measurements to evaluate the dimensions of the wound, the circumference yielding a better determination of the wounds extent in situations where the wound has an irregular geometry. #### Intended Use(s) 807.92(a)(5) Pie Medical's Picus, Parus, Falco & Aquila Ultrasound Imaging Systems are to be used by or under the direction of a physician to perform general noninvasive and invasive diagnostic high resolution ultrasound imaging studies, to include: fetal, cardiac, transrectal, transvaginal, abdominal, neonatal cephalic, pediatric, peripheral vascular, small organs, intraoperative abdominal, intraoperative vascular, musculoskeletal (conventional and superficial) and wounds. {2}------------------------------------------------ | General
characteristics | ' Pie Medical
Picus, Parus, Falco &
Aquila Systems
This Submission | Pie Medical
Picus, Parus, Falco &
Aquila Systems
K002880/023513/
003725 | Hudson Diagnostic
Imaging
Hudson
2020/2040/2060
Systems
K022928 | |----------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------| | Intended Use | Fetal, Abdominal, Pediatric,
Small Organ, Intraoperative
abdominal, Peripheral
vascular, Cardiac,
Transrectal, Transvaginal,
Musculoskeletal-
conventional & superficial,
Abdominal, Neonatal
Cephalic & Wounds | Fetal, Abdominal,
Pediatric, Small Organ,
Intraoperative
abdominal, Peripheral
vascular, Cardiac,
Transrectal,
Transvaginal,
Musculoskeletal-
conventional &
superficial, Abdominal,
Neonatal Cephalic &
Wounds | Wounds | | Transducer Type | Linear | 8.0 Mhz 30C/40mm
(#410647)
7.5 Mhz 40mm
(#410503) | 8.0 Mhz 40mm
(#402198)
6-8 Mhz 60mm
(#410054)
5.0 Mhz 40mm
(#410503) | | | | 8.0 Mhz 30C/40mm
(#410647)
7.5 Mhz 40mm
(#410503) | | | General
characteristics | ¹ Pie Medical
Picus, Parus, Falco &
Aquila Systems
This Submission | Pie Medical
Picus, Parus, Falco &
Aquila Systems
K002880/023513/
003725 | Hudson Diagnostic
Imaging
Hudson
2020/2040/2060
Systems
K022928 | | Imaging Modes | 2D / M-mode | 2D / M-mode
3D (Picus) | 2D / M-mode | | Safety | | | | | Electrical Safety | EN60601-1 | EN60601-1 | EN60601-1 | | Ultrasound Safety | Track 1/3 | Track 1/3 | Track 1/3 | {3}------------------------------------------------ # 8007.92(a)(6) {4}------------------------------------------------ Image /page/4/Picture/1 description: The image shows a circular seal with an emblem in the center. The emblem consists of three parallel, curved lines that resemble a stylized bird or wing design. Encircling the emblem is text that reads "U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES - USA". The text is arranged along the perimeter of the circle, with the emblem positioned in the center. Public Health Service JUL 2 3 2004 Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 Pie Medical % Ms. Carrie Graham Consultant The Anson Group 7992 Castleway Drive INDIANAPOLIS IN 46250 Re: K041675 Trade Name: Picus, Parus, Falco, and Aquila Ultrasound Imaging System Regulation Number: 21 CFR 892.1550 Regulation Name: Ultrasonic pulsed doppler imaging system Regulation Name: 21 CFR 892.1560 Regulation Name: Ultrasonic pulsed echo imaging system Regulation Number: 21 CFR 892.1570 Regulation Name: Diagnostic ultrasonic transducer Regulatory Class: II Product Code: 90 IYN, IYO, and ITX Dated: June 18, 2004 Received: June 21, 2004 Dear Ms. Graham: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. This determination of substantial equivalence applies to the following transducers intended for use with the Picus, Parus, Falco, and Aquila Ultrasound Imaging System, as described in your premarket notification: ### Transducer Model Number ### 7.5 MHz L40, Picus 8MHz LA DF 30C/40mm, Parus, Falco, & Aquila {5}------------------------------------------------ If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device it may or secreer to basis of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must or any I vith all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus permits your device to proceed to market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801, please 11 you the Office of Compliance at (301) 594-4591. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or at (301) 443-6597 or at its Internet address "http://www.fda.gov/cdrh/dsmamain.html". If you have any questions regarding the content of this letter, please contact Rodrigo C. Perez at (301) 594-1212. Sincerely yours, David A. Lyman Image /page/5/Picture/8 description: The image contains a handwritten word, "for", in cursive script. The word is written in black ink on a white background. The letter "f" has a long, curved descender, and the "o" and "r" are connected. The writing appears to be somewhat stylized. Nancy C. Brogdon Director, Division of Reproductive, Abdominal and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure(s) {6}------------------------------------------------ # Diagnostic Ultrasound Indications for Use Form - Appendix F #### Parus System | | | Mode of Operation | | | | | | | | | |----------------------------------|---|-------------------|---|-----|-----|------------------|----------------------|------------------------------|-----------------------|--------------------| | Clinical Application | A | B | M | PWD | CWD | Color
Doppler | Amplitude
Doppler | Color
Velocity
Imaging | Combined
(specify) | Other
(specify) | | Ophthalmic | | | | | | | | | | | | Fetal | | P | P | | | | | | P [2] | | | Abdominal | | P | P | | | | | | P [2] | | | Intraoperative (Abdominal) | | P | P | | | | | | | | | Intraoperative Neurological | | | | | | | | | | | | Pediatric | | P | P | | | | | | P [2] | | | Small Organ (specify) [1] | | P | P | | | | | | P [2] | | | Neonatal Cephalic | | P | P | | | | | | P [2] | | | Adult Cephalic | | | | | | | | | | | | Cardiac | | P | P | | | | | | P [2] | | | Transesophageal | | | | | | | | | | | | Transrectal | | P | P | | | | | | P [2] | | | Transvaginal | | P | P | | | | | | P [2] | | | Transurethral | | | | | | | | | | | | Intravascular | | | | | | | | | | | | Peripheral Vascular | | P | P | | | | | | P (2) | | | Laparoscopic | | | | | | | | | | | | Musculo-skeletal
Conventional | | P | P | | | | | | P [2] | | | Musculo-skeletal Superficial | | P | P | | | | | | P [2] | | | Other - Wounds | | N | | | | | | | | | Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows: N=new indication; P=previously cleared by FDA; E= added under Appendix E Additional Comments: [1] Small organs include Thyroid, Breast and Testicles. [2] Applicable combined modes: B+B; B+M (PLEASE DO NOT WRITE BELOW THIS LINE. CONTINUE ON ANOTHER PAGE IF NEEDED Concurrence of CDRH, Office of Device Evaluation (ODE) Daniel A. Leyman (Division Sign-Off) Division of Reproductive, and Radiological Devic 510(k) Number {7}------------------------------------------------ Falco System | Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows. | | | |--------------------------------------------------------------------------------------------------|--|--| |--------------------------------------------------------------------------------------------------|--|--| | | Mode of Operation | | | | | | | | | | |----------------------------------|-------------------|---|---|-----|-----|------------------|----------------------|------------------------------|-----------------------|--------------------| | Clinical Application | A | B | M | PWD | CWD | Color
Doppler | Amplitude
Doppler | Color
Velocity
Imaging | Combined
(specify) | Other
(specify) | | Ophthalmic | | | | | | | | | | | | Fetal | | P | P | | | | | | P [2] | | | Abdominal | | P | P | | | | | | | | | Intraoperative (Abdominal) | | P | P | | | | | | P [2] | - | | Intraoperative Neurological | | | | | | | | | | | | Pediatric | | P | P | | | | | | P [2] | | | Small Organ (specify) [1] | | P | P | | | | | | P [2] | | | Neonatal Cephalic | | P | P | | | | | | P [2] | | | Adult Cephalic | | | | | | | | | | | | Cardiac | | P | P | | | | | | P[2] | | | Transesophageal | | | | | | | | | | | | Transrectal | | P | P | | | | | | | | | Transvaginal | | P | P | | | | | | | | | Transurethral | | | | | | | | | | | | Intravascular | | | | | | | | | | | | Peripheral Vascular | | P | P | | | | | | P [2] | | | Laparoscopic | | | | | | | | | | | | Musculo-skeletal
Conventional | | P | P | | | | | | P [2] | | | Musculo-skeletal Superficial | | P | P | | | | | | P [2] | | | Other - Wounds | | N | | | | | | | | | N=new indication; P=previously cleared by FDA; E= added under Appendix E Additional Comments: [1] Small organs include Thyroid, Breast and Testicles. [2[ Applicable combined modes: B+B; B+M (PLEASE DO NOT WRITE BELOW THIS LINE. CONTINUE ON ANOTHER PAGE IF NEEDED Concurrence of CDRH. Office of Device Evaluation (ODE) Daniel C. Boyann (Division Sign-Off) Division of Reproductive, I and Radiological Devices 510(k) Number _ {8}------------------------------------------------ Aquila System | | Mode of Operation | | | | | | | | | | |----------------------------------|-------------------|---|---|-----|-----|------------------|----------------------|------------------------------|-----------------------|--------------------| | Clinical Application | A | B | M | PWD | CWD | Color
Doppler | Amplitude
Doppler | Color
Velocity
Imaging | Combined
(specify) | Other
(specify) | | Ophthalmic | | | | | | | | | | | | Fetal | | P | P | | | | | | P [2] | | | Abdominal | | P | P | | | | | | P [2] | - | | Intraoperative (Abdominal) | | P | P | | | | | | P [2] | | | Intraoperative Neurological | | | | | | | | | | | | Pediatric | | P | P | | | | | | P [2] | | | Small Organ (specify) [1] | | P | P | | | | | | P [2] | | | Neonatal Cephalic | | P | P | | | | | | P [2] | | | Adult Cephalic | | | | | | | | | | | | Cardiac | | P | P | | | | | | P [2] | | | Transesophageal | | | | | | | | | | | | Transrectal | | P | P | | | | | | P [2] | | | Transvaginal | | P | P | | | | | | P [2] | | | Transurethral | | | | | | | | | | | | Intravascular | | | | | | | | | | | | Peripheral Vascular | | P | P | | | | | | P [2] | | | Laparoscopic | | | | | | | | | | | | Musculo-skeletal
Conventional | | P | P | | | | | | P [2] | | | Musculo-skeletal Superficial | | P | P | | | | | | P [2] | | | Other - Wounds | | N | | | | | | | | | Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows: N=new indication; P=previously cleared by FDA; E= added under Appendix E Additional Comments: [1] Small organs include Thyroid, Breast and Testicles. [2] Applicable Combined Modes: B+B; B+M (PLEASE DO NOT WRITE BELOW THIS LINE. CONTINUE ON ANOTHER PAGE IF NEEDED Concurrence of CDRH, Office of Device Evaluation (ODE) Damil A. Sypm (Division Sign-Off) Division of Reproductive, Al and Radiological Devices 1 ( ( ) Number __ {9}------------------------------------------------ Picus System | | Mode of Operation | | | | | | | | | | | |----------------------------------|-------------------|---|---|------------|-----|--------------------------|------------------------------|------------------------------|-----------------------|--------------------------|--| | Clinical Application | A | B | M | PWD
(D) | CWD | Color
Doppler
(CD) | Amplitude
Doppler
(AD) | Color
Velocity
Imaging | Combined
(specify) | Other
(specify)
3D | | | Ophthalmic | | | | | | | | | | | | | Fetal | | P | P | P | | P | P | | P[2] | P | | | Abdominal | | P | P | P | | P | P | | P[2] | P | | | Intraoperative (specify) | | | | | | | | | | | | | Intraoperative Neurological | | | | | | | | | | | | | Pediatric | | | | | | | | | | | | | Small Organ (specify) [1] | | P | P | P | | P | P | | P[2] | P | | | Neonatal Cephalic | | P | P | P | | P | P | | P[2] | P | | | Adult Cephalic | | | | | | | | | | | | | Cardiac | | P | P | P | | P | P | | P[2] | P | | | Transesophageal | | | | | | | | | | | | | Transrectal | | P | P | P | | P | P | | P[2] | P | | | Transvaginal | | P | P | P | | P | P | | P[2] | P | | | Transurethral | | | | | | | | | | | | | Intravascular | | | | | | | | | | | | | Peripheral Vascular | | P | P | P | | P | P | | P[2] | P | | | Laparoscopic | | | | | | | | | | | | | Musculo-skeletal
Conventional | | P | P | P | | P | P | | P[2] | | | | Musculo-skeletal Superficial | | P | P | P | | P | P | | P[2] | | | | Other - Wounds | | N | | | | | | | | | | Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows: N=new indication; P=previously cleared by FDA; E= added under Appendix E Additional Comments: [1] Small organs include Thyroid, Breast and Testicles. [2] Applicable combined modes: B+D; B+CD+D; B+AD+D (PLEASE DO NOT WRITE BELOW THIS LINE. CONTINUE ON ANOTHER PAGE IF NEEDED Concurrence of CDRH, Office of Device Evaluation (ODE) David A. Severson (Division Sign-Division of Reprodu and Radiological De 510(k) Numbe {10}------------------------------------------------ Probe #410503 - Picus 7.5 MHz L40 | Clinical Application | A | B | M | PWD
(D) | CWD | Color
Doppler
(CD) | Amplitude
Doppler
(AD) | Color
Velocity
Imaging | Combined
(specify) | Other
(specify)
3D | |----------------------------------|---|---|---|------------|-----|--------------------------|------------------------------|------------------------------|-----------------------|--------------------------| | Ophthalmic | | | | | | | | | | | | Fetal | | | | | | | | | | | | Abdominal | | | | | | | | | - | | | Intraoperative (specify) | | | | | | | | | | | | Intraoperative Neurological | | | | | | | | | | | | Pediatric | | | | | | | | | | | | Small Organ (specify) [1] | | P | P | P | | P | P | | P [2] | P | | Neonatal Cephalic | | | | | | | | | | | | Adult Cephalic | | | | | | | | | | | | Cardiac | | | | | | | | | | | | Transesophageal | | | | | | | | | | | | Transrectal | | | | | | | | | | | | Transvaginal | | | | | | | | | | | | Transurethral | | | | | | | | | | | | Intravascular | | | | | | | | | | | | Peripheral Vascular | | P | P | P | | P | P | | P [2] | P | | Laparoscopic | | | | | | | | | | | | Musculo-skeletal
Conventional | | P | P | P | | P | P | | P[2] | | | Musculo-skeletal Superficial | | P | P | P | | P | P | | P[2] | | | Other - Wounds | | N | | | | | | | | | Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows N=new indication; P=previously cleared by FDA; E= added under Appendix E Additional Comments: [1] Small organs include Thyroid, Breast and Testicles. [2] Applicable combined modes: B+D; B+CD+D; B+AD+D (PLEASE DO NOT WRITE BELOW THIS LINE. CONTINUE ON ANOTHER PAGE IF NEEDED Concurrence of CDRH, Otfice of Device Evaluation (ODE) Daniel G. Ingram (Division Sign-Off Division of and Radiolog 510(k) Number {11}------------------------------------------------ # Diagnostic Ultrasound Indications for Use Form - Appendix F Probe# 410647 - Parus, Falco & Aquila 8MHz LA DF 30C/40mm | | Mode of Operation | | | | | | | | | | |----------------------------------|-------------------|---|---|-----|-----|------------------|----------------------|------------------------------|-----------------------|--------------------------| | Clinical Application | A | B | M | PWD | CWD | Color
Doppler | Amplitude
Doppler | Color
Velocity
Imaging | Combined
(specify) | Other
(specify)
3D | | Ophthalmic | | | | | | | | | | | | Fetal | | | | | | | | | | | | Abdominal | | | | | | | | | P [2] | | | Intraoperative (Abdominal) | P | P | P | | | | | | P [2] | | | Intraoperative Neurological | | | | | | | | | | | | Pediatric | | P | P | | | | | | P [2] | | | Small Organ (specify) [1] | | P | P | | | | | | P [2] | | | Neonatal Cephalic | | | | | | | | | | | | Adult Cephalic | | | | | | | | | | | | Cardiac | | | | | | | | | | | | Transesophageal | | | | | | | | | | | | Transrectal | | | | | | | | | | | | Transvaginal | | | | | | | | | | | | Transurethral | | | | | | | | | | | | Intravascular | | | | | | | | | | | | Peripheral Vascular | | P | P | | | | | | P [2] | | | Laparoscopic | | | | | | | | | | | | Musculo-skeletal
Conventional | | P | P | | | | | | P [2] | | | Musculo-skeletal Superficial | | P | P | | | | | | P [2] | | | Other - Wounds | N | N | | | | | | | | | Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows: N=new indication; P=previously cleared by FDA; E= added under Appendix E Additional Comments: [1] Small organs include Thyroid, Breast and Testicles. [2] Applicable combined modes: B+B; B+M (PLEASE DO NOT WRITE BELOW THIS LINE. CONTINUE ON ANOTHER PAGE IF NEEDED Concurrence of CDRH, Office of Device Evaluation (ODE) Daniel A. Seymour (Division Sign-O nroductive and Radi 510(k) Num --- **Source:** [https://fda.innolitics.com/submissions/RA/subpart-b%E2%80%94diagnostic-devices/IYN/K041675](https://fda.innolitics.com/submissions/RA/subpart-b%E2%80%94diagnostic-devices/IYN/K041675) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com